Epidermal Growth Factor Receptor and Extracapsular Spread in Oral Cancer
Author Information
Author(s): Michikawa C, Uzawa N, Sato H, Ohyama Y, Okada N, Amagasa T
Primary Institution: Tokyo Medical and Dental University
Hypothesis
Is extracapsular spread (ECS) an important prognostic indicator in oral squamous cell carcinomas (OSCCs)?
Conclusion
ECS is an independent prognostic factor in OSCCs, and the number of positive lymph nodes and EGFR numerical aberrations are excellent predictors of ECS.
Supporting Evidence
- ECS is significantly associated with high rates of loco-regional recurrence and poor outcomes.
- Patients with ECS require intensified multimodality therapy.
- EGFR numerical aberrations in primary tumors are linked to ECS in metastatic lymph nodes.
Takeaway
Doctors found that if cancer spreads outside the lymph nodes, it can make the cancer worse. They also discovered that checking a specific gene can help find patients who might need more treatment.
Methodology
The study analyzed 127 OSCC patients, examining factors like primary tumor features and gene copy number aberrations using fluorescence in situ hybridization.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the reliance on histological examination post-surgery.
Limitations
The study is retrospective and relies on data from medical records, which may have inherent biases.
Participant Demographics
The study included 127 patients, predominantly men (67.7%), with a mean age of 60.2 years.
Statistical Information
P-Value
0.001 for number of positive nodes, 0.004 for EGFR numerical aberrations
Confidence Interval
95% CI=2.136–41.370 for positive nodes, 1.631–41.295 for EGFR aberrations
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website